Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial.

@article{Sharples2012ClinicalEA,
  title={Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial.},
  author={Linda D. Sharples and Cathy M Jackson and Ella Wheaton and Gwen Griffith and Jouke Tabe Annema and Christophe A Dooms and Kurt G. Tournoy and E. Deschepper and Vikki Hughes and Lavinia Magee and Martin Buxton and Robert C Rintoul},
  journal={Health technology assessment},
  year={2012},
  volume={16 18},
  pages={1-75, iii-iv}
}
OBJECTIVE To assess the clinical effectiveness and cost-effectiveness of endosonography (followed by surgical staging if endosonography was negative), compared with standard surgical staging alone, in patients with non-small cell lung cancer (NSCLC) who are otherwise candidates for surgery with curative intent. DESIGN A prospective, international, open-label, randomised controlled study, with a trial-based economic analysis. SETTING Four centres: Ghent University Hospital, Belgium; Leuven… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Similar Papers

Loading similar papers…